Skip to main content
. 2017 Mar 30;12(3):e0170422. doi: 10.1371/journal.pone.0170422

Table 3. Top hits from the genome-wide screen for Achilles tendon injury and ACL rupture (p<1x10-6).

Achilles tendon injury
SNP EAa MAFb P (FE)c OR (FE)(95% CI)d P (RE) OR (RE) (95% CI)
rs1937810 C 0.17 1.5x10-7 1.16 (1.11–1.21) 1.5x10-7 1.16 (1.11–1.21)
rs57104447 C 0.04 3.0x10-7 1.28 (1.19–1.37) .01 1.25 (1.16–1.34)
rs57224706 G 0.03 6.0x10-7 1.36 (1.24–1.48) 6.0x10-7 1.36 (1.24–1.48)
rs60713544 C 0.02 7.2x10-7 1.43 (1.29–1.57) 7.2x10-7 1.43 (1.29–1.57)
ACL rupture
SNP EAa MAFb P (FE)c OR (FE) (95% CI)d P (RE) OR (RE) (95% CI)
rs4067493 G 0.04 2.4x10-7 1.94(1.69–2.19) 3.1x10-5 2.06(1.81–2.31)
rs113435565 C 0.03 4.0x10-7 1.91 (1.66–2.16) 4.0x10-7 1.91 (1.66–2.16)
rs11960097 G 0.08 5.9x10-7 1.54 (1.37–1.71) 5.9x10-7 1.54 (1.37–1.71)

aEffect allele.

bMinor Allele Frequency in the control population.

cP-value from fixed effects (FE) or random effects (RE) meta-analysis.

dAllelic odds ratio (95% confidence interval) for the effect allele. FE, fixed effect; RE, random effect.